{"id":71400,"date":"2026-05-20T09:01:36","date_gmt":"2026-05-20T09:01:36","guid":{"rendered":"https:\/\/medsbase.com\/pinealon\/"},"modified":"2026-10-15T10:33:57","modified_gmt":"2026-10-15T10:33:57","slug":"pinealon","status":"publish","type":"product","link":"https:\/\/medsbase.com\/fr\/product\/pinealon\/","title":{"rendered":"Pinealon"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">R\u00e9ponse rapide \u2014 Qu'est-ce que le Pinealon ?<\/h3>\n<p style=\"margin: 0;\"><strong>Pinealon<\/strong> is a synthetic tripeptide (sequence Glu-Asp-Arg, EDR) belonging to the Khavinson short-peptide bioregulator family developed at the St. Petersburg Institute of Bioregulation and Gerontology. Originally derived from cattle pineal-gland-extract studies, Pinealon is studied for neuroprotective, anti-oxidant, and cognitive-aging effects in clinical models \u2014 with a proposed mechanism involving direct nuclear access and chromatin-level gene-expression regulation. Sibling peptide to <a href=\"https:\/\/medsbase.com\/fr\/epitalon\/\">Epitalon<\/a> within the Khavinson series. Supplied in 5 mg, 10 mg, and 20 mg lyophilized vials.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>Ce que vous obtenez avec MedsBase :<\/strong> Pharmaceutical-grade lyophilized peptides &middot; HPLC &ge;99% purity (COA on request) &middot; Discreet protective packaging &middot; Worldwide peptide courier &middot; 1,400+ verified <a href=\"https:\/\/medsbase.com\/fr\/reviews\/\">avis clients<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Chaque commande est couverte par notre <a href=\"https:\/\/medsbase.com\/fr\/medsbase-re-shipment-assurance-policy\/\"><strong>Politique de R\u00e9exp\u00e9ditions Garanties<\/strong><\/a> \u2014 si votre colis n'arrive pas dans les 20 jours ouvrables, nous le r\u00e9exp\u00e9dions.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">Sp\u00e9cification<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">D\u00e9tail<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Num\u00e9ro CAS<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">308067-43-8 (couramment cit\u00e9 ; toutes les sources de peptides chez les fournisseurs ne publient pas de num\u00e9ro d'enregistrement)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Type<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Synthetic tripeptide bioregulator (Khavinson short-peptide family) \u2014 developed at the St. Petersburg Institute of Bioregulation and Gerontology by Vladimir Khavinson; originally based on cattle pineal-gland extract studies. Pinealon is the cognitive \/ neuroprotective member of the Khavinson series, paired with <a href=\"https:\/\/medsbase.com\/fr\/epitalon\/\">Epitalon<\/a> (long\u00e9vit\u00e9\/t\u00e9lom\u00e9rase) comme \u00e9tant les deux compos\u00e9s les plus \u00e9tudi\u00e9s.<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Formule mol\u00e9culaire<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>15<\/sub>H<sub>26<\/sub>N<sub>6<\/sub>O<sub>8<\/sub><\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Masse mol\u00e9culaire<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">~418,4 Da<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>S\u00e9quence<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">H-Glu-Asp-Arg-OH (EDR) \u2014 s\u00e9quence lin\u00e9aire \u00e0 3 r\u00e9sidus. Extr\u00e9mit\u00e9s N et C libres ; pas de pont disulfure, pas d'acylation, pas de PEGylation. Charge nette +1 \u00e0 pH neutre (un Arg cationique \u00e9quilibr\u00e9 par les groupes carboxylate de Glu\/Asp).<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Forme<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Poudre lyophilis\u00e9e (blanche \u00e0 blanc cass\u00e9)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Puret\u00e9<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599 % (v\u00e9rifi\u00e9 par HPLC, COA sur demande)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Stockage<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Lyophilis\u00e9 : 2\u20138 \u00b0C (r\u00e9frig\u00e9rateur) pour le stock de travail ; \u221220 \u00b0C pour le stockage \u00e0 long terme des flacons non ouverts. Reconstitu\u00e9 : 2\u20138 \u00b0C, utiliser dans les ~14\u201328 jours. Prot\u00e9ger de la lumi\u00e8re. \u00c9viter les cycles r\u00e9p\u00e9t\u00e9s de cong\u00e9lation-d\u00e9cong\u00e9lation de la solution reconstitu\u00e9e.<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Solubilit\u00e9<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Hautement soluble dans l'eau bact\u00e9riostatique ou st\u00e9rile \u2014 les tripeptides charg\u00e9s courts se dissolvent rapidement avec un l\u00e9ger mouvement circulaire. Aucun solvant sp\u00e9cialis\u00e9 requis.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>Qu'est-ce que le Pinealon ?<\/h2>\n<p><strong>Pinealon<\/strong> is a synthetic tripeptide consisting of L-glutamic acid, L-aspartic acid, and L-arginine (sequence Glu-Asp-Arg, single-letter code EDR). It is a member of the Khavinson short-peptide bioregulator family \u2014 a group of 2- to 4-amino-acid peptides developed at the St. Petersburg Institute of Bioregulation and Gerontology under Vladimir Khavinson, originally based on the fractionation and characterisation of bioactive material extracted from cattle pineal gland and other tissues. Within the Khavinson series, Pinealon is the compound most associated with cognitive function and neuroprotection in published studies, while its sibling tetrapeptide <a href=\"https:\/\/medsbase.com\/fr\/epitalon\/\">Epitalon<\/a> (Ala-Glu-Asp-Gly, AEDG) is the most-studied compound in the longevity \/ telomerase context. Khavinson short peptides differ structurally from most other peptides in two important ways: <strong>ils sont extr\u00eamement courts<\/strong> (Pinealon ne compte que trois r\u00e9sidus, PM ~418 Da, plus petit qu'une petite mol\u00e9cule m\u00e9dicament typique) et <strong>leur m\u00e9canisme propos\u00e9 repose sur un acc\u00e8s nucl\u00e9aire direct<\/strong> rather than receptor binding at the plasma membrane. The published Khavinson model holds that short charged peptides can cross both the cell membrane and the nuclear envelope, reach chromatin, and modulate gene expression through sequence-specific interactions with DNA \u2014 a mechanism distinct from the canonical receptor-binding pharmacology of larger peptides. This model is supported by published studies from the Khavinson group spanning several decades and is the subject of continued mechanistic investigation by independent users. Pinealon has been investigated in clinical contexts focused on cognitive aging, oxidative-stress protection of neuronal cultures, cerebral ischemia models, and circadian \/ pineal-axis studies. It is <strong>non approuv\u00e9<\/strong> by the FDA, EMA, MHRA, or any other major regulator for human therapeutic use. <\/p>\n<h2>M\u00e9canisme d'action \u2014 Bioregulation par peptides courts de Khavinson<\/h2>\n<p>The published mechanistic model for Khavinson short peptides \u2014 supported by studies from the Khavinson group and tested in independent laboratories \u2014 proposes three principal modes of action:<\/p>\n<ul>\n<li><strong>Acc\u00e8s nucl\u00e9aire direct et r\u00e9gulation de l'expression g\u00e9nique par liaison \u00e0 l'ADN<\/strong> \u2014 Les peptides courts de Khavinson sont propos\u00e9s pour traverser la membrane plasmique et l'enveloppe nucl\u00e9aire et atteindre directement la chromatine. Le mod\u00e8le publi\u00e9 soutient que les s\u00e9quences courtes charg\u00e9es (contenant g\u00e9n\u00e9ralement des combinaisons de r\u00e9sidus Glu\/Asp\/Arg\/Lys) peuvent \u00e9tablir des contacts sp\u00e9cifiques de s\u00e9quence avec le grand ou le petit sillon de l'ADN de forme B au niveau des r\u00e9gions promotrices, modulant la transcription de panels de g\u00e8nes sp\u00e9cifiques. Pinealon (Glu-Asp-Arg) a \u00e9t\u00e9 associ\u00e9 dans des travaux publi\u00e9s \u00e0 une r\u00e9gulation positive des g\u00e8nes impliqu\u00e9s dans la d\u00e9fense antioxydante, la fonction mitochondriale et la survie neuronale.<\/li>\n<li><strong>Effets antioxydants et protecteurs mitochondriaux<\/strong> \u2014 Dans des mod\u00e8les de cultures neuronales et in vivo chez les rongeurs, l'administration de Pinealon est rapport\u00e9e pour r\u00e9duire les marqueurs des esp\u00e8ces r\u00e9actives de l'oxyg\u00e8ne (ROS), pr\u00e9server le potentiel de membrane mitochondriale sous stress (hyperoxie, hypoxie, excitotoxicit\u00e9 du glutamate) et diminuer les signaux apoptotiques. Ces effets sont en aval de la modulation de l'expression g\u00e9nique plut\u00f4t qu'un pi\u00e9geage direct des radicaux.<\/li>\n<li><strong>Neuroprotection dans les mod\u00e8les de vieillissement cognitif<\/strong> \u2014 Des \u00e9tudes comportementales chez des rongeurs \u00e2g\u00e9s ont rapport\u00e9 des am\u00e9liorations des performances d'apprentissage spatial et de m\u00e9moire de travail apr\u00e8s l'administration de Pinealon par rapport \u00e0 des t\u00e9moins appari\u00e9s pour l'\u00e2ge. Le m\u00e9canisme est interpr\u00e9t\u00e9 comme une combinaison de protection antioxydante des populations neuronales vuln\u00e9rables (CA1 hippocampique, couche corticale V) et d'effets directs sur l'expression g\u00e9nique dans les neurones soutenant la machinerie de la plasticit\u00e9 synaptique.<\/li>\n<\/ul>\n<p>Khavinson short peptides have very short plasma half-lives (minutes), but proposed effects persist for hours to days through downstream gene-expression cascades \u2014 a profile broadly similar to other receptor-trigger peptides where duration is set by signalling-cascade kinetics rather than by sustained plasma residence. Subcutaneous administration is the standard route in published studies protocols. <\/p>\n<h2>Published Evidence<\/h2>\n<p>Pinealon is used in clinical contexts that investigate:<\/p>\n<ul>\n<li><strong>Cognitive-aging studies<\/strong> \u2014 spatial learning, working memory, and behavioural performance in aged-rodent models; the most-studied application for Pinealon<\/li>\n<li><strong>Protection contre le stress oxydatif des cultures neuronales<\/strong> \u2014 protection des cultures primaires corticales et hippocampiques contre H<sub>2<\/sub>O<sub>2<\/sub>, excitotoxicit\u00e9 du glutamate, hyperoxie ; mesures des ROS et du potentiel membranaire mitochondrial<\/li>\n<li><strong>Mod\u00e8les d'isch\u00e9mie c\u00e9r\u00e9brale \/ AVC<\/strong> \u2014 l\u00e9sion d'isch\u00e9mie-reperfusion dans les mod\u00e8les d'occlusion de l'art\u00e8re c\u00e9r\u00e9brale moyenne (MCAO) chez les rongeurs ; mesures du volume de l'infarctus et des d\u00e9ficits comportementaux<\/li>\n<li><strong>Neurodegenerative-disease in-vitro studies<\/strong> \u2014 mod\u00e8les de toxicit\u00e9 de type Alzheimer A\u03b2 et de toxicit\u00e9 de type Parkinson \u03b1-synucl\u00e9ine dans les neurones cultiv\u00e9s ; travaux publi\u00e9s sur les lign\u00e9es PC12 et SH-SY5Y<\/li>\n<li><strong>Hypoxia and high-altitude studies<\/strong> \u2014 performance cognitive et comportementale dans des conditions hypobares\/hypoxiques<\/li>\n<li><strong>Pineal-axis and circadian rhythm support<\/strong> \u2014 historical pineal-gland-extract origin makes Pinealon a tool for examining pineal-axis modulation of circadian gene expression, though most current studies focuses on neuroprotection rather than circadian rhythm per se<\/li>\n<li><strong>Pharmacologie comparative des peptides de Khavinson<\/strong> \u2014 comparaison c\u00f4te \u00e0 c\u00f4te avec <a href=\"https:\/\/medsbase.com\/fr\/epitalon\/\">Epitalon<\/a> (AEDG, long\u00e9vit\u00e9\/t\u00e9lom\u00e9rase), Vilon (KE, immunit\u00e9), et Livagen (KEDA, h\u00e9patoprotection) pour diss\u00e9quer la sp\u00e9cificit\u00e9 s\u00e9quentielle des effets des peptides courts<\/li>\n<\/ul>\n<p>For broader context on neuroactive short peptides and related compounds, see <a href=\"https:\/\/medsbase.com\/fr\/epitalon\/\">Epitalon<\/a> (t\u00e9trapeptide de Khavinson apparent\u00e9), <a href=\"https:\/\/medsbase.com\/fr\/semax\/\">Semax<\/a> (heptapeptide d\u00e9riv\u00e9 de l'ACTH, am\u00e9lioration cognitive), <a href=\"https:\/\/medsbase.com\/fr\/selank\/\">Selank<\/a> (anxiolytique\/nootrope d\u00e9riv\u00e9 de la tuftsine), et <a href=\"https:\/\/medsbase.com\/fr\/dsip\/\">DSIP<\/a> (peptide inducteur du sommeil delta). Parcourez l'int\u00e9gralit\u00e9 de <a href=\"https:\/\/medsbase.com\/fr\/peptides\/\">catalogue de peptides<\/a> pour les compos\u00e9s associ\u00e9s. <\/p>\n<h2>Forces et concentrations disponibles<\/h2>\n<p>MedsBase stocks Pinealon in three lyophilized vial sizes calibrated to typical protocol lengths. Each strength is available in 10-vial, 20-vial, or 30-vial pack formats:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Concentration du flacon<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Cas d'utilisation typique<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Tailles de conditionnement<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>5 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Dosage pilote \u2014 protocoles courts sur le vieillissement cognitif, titrage dose-r\u00e9ponse, travaux in vitro sur le stress oxydatif<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 ou 30 flacons<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>10 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Standard strength \u2014 multi-week cognitive-aging studies, MCAO ischemia models, multi-cohort protocols<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 ou 30 flacons<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>20 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Protocoles \u00e0 cycles prolong\u00e9s \u2014 \u00e9tudes sur le vieillissement \u00e0 long terme, travaux comportementaux sur de grandes cohortes, co\u00fbt par mg le plus bas<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 ou 30 flacons<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>All three strengths are the same chemical form (lyophilized powder, \u226599% HPLC purity). Published studies protocols use a wide dose range depending on model and route \u2014 typically 100 \u00b5g\u20134 mg per kg body weight in rodent models. Determine dose ranges from peer-reviewed literature appropriate to your specific protocol. <\/p>\n<h2>Comparaison \u2014 Pinealon vs Epitalon<\/h2>\n<p>Pinealon et <a href=\"https:\/\/medsbase.com\/fr\/epitalon\/\">Epitalon<\/a> are the two most-studied compounds in the Khavinson short-peptide family. Both are short charged peptides developed by the same group and share the proposed direct-nuclear-access mechanism, but they have entirely different sequence specificity and different best-studied applications. <\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Crit\u00e8re<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Pinealon<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Epitalon<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>S\u00e9quence<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Glu-Asp-Arg (EDR)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Ala-Glu-Asp-Gly (AEDG)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Longueur<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">3 acides amin\u00e9s (tripeptide)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">4 acides amin\u00e9s (t\u00e9trapeptide)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Masse mol\u00e9culaire<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">~418 Da<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">~390 Da<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Charge nette<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">+1 (Arg \u00e9quilibre Glu\/Asp)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u22122 (Glu\/Asp dominent ; pas de r\u00e9sidus cationiques)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Best-studied studies focus<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Vieillissement cognitif, neuroprotection, protection contre le stress oxydatif des cultures neuronales<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Telomerase activation, lifespan extension, longevity studies<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Origine tissulaire (propos\u00e9e)<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Fractionnement d'extrait de glande pin\u00e9ale bovine<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Fractionnement d'extrait de glande pin\u00e9ale bovine<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>M\u00e9canisme propos\u00e9<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Acc\u00e8s nucl\u00e9aire direct ; modulation de l'expression des g\u00e8nes antioxydants et mitochondriaux<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Acc\u00e8s nucl\u00e9aire direct ; liaison propos\u00e9e au promoteur de la t\u00e9lom\u00e9rase<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Demi-vie plasmatique<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Minutes (l'effet persiste via des cascades en aval)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Minutes (l'effet persiste via des cascades en aval)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>For studies focused on neuroprotection, cognitive-aging models, or oxidative-stress protection of neuronal cultures, Pinealon is the more targeted Khavinson peptide. For studies focused on telomerase activation, replicative-senescence reversal, or longevity-axis pharmacology, <a href=\"https:\/\/medsbase.com\/fr\/epitalon\/\">Epitalon<\/a> remains the more widely-studied option. Some protocols use both compounds in parallel to dissect the sequence-specificity of Khavinson short-peptide effects. <\/p>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 14px 18px; margin: 18px 0;\"><strong class=\"mb-bac-water-callout\">\ud83d\udca7 Besoin d'eau BAC ?<\/strong> La reconstitution de tout flacon lyophilis\u00e9 n\u00e9cessite de l'eau bact\u00e9riostatique st\u00e9rile. Associez ce produit \u00e0 notre <a href=\"\/fr\/bac-water\/\"><strong>Eau BAC (Eau bact\u00e9riostatique)<\/strong><\/a> \u2014 flacon multidose de 30 mL, pr\u00e9serv\u00e9 par 0,9 % d'alcool benzylique, qualit\u00e9 USP.<\/div>\n<h2>Stockage et reconstitution<\/h2>\n<p><strong>Avant la reconstitution :<\/strong> conserver les flacons lyophilis\u00e9s au r\u00e9frig\u00e9rateur \u00e0 2\u20138 \u00b0C dans leur emballage d'origine pour le stock de travail \u00e0 court terme. Pour le stockage \u00e0 long terme, congeler les flacons non ouverts \u00e0 \u221220 \u00b0C. Le Pinealon lyophilis\u00e9 est stable sous r\u00e9frig\u00e9ration jusqu'\u00e0 24 mois et \u00e0 \u221220 \u00b0C jusqu'\u00e0 36 mois. \u00c9viter les cycles de cong\u00e9lation-d\u00e9cong\u00e9lation de la poudre lyophilis\u00e9e. Le Pinealon est un tripeptide court non modifi\u00e9 sans pont disulfure ni cha\u00eene acyle \u2014 sa manipulation est parmi les plus simples du catalogue. <strong>Proc\u00e9dure de reconstitution :<\/strong> injecter de l'eau bact\u00e9riostatique le long de la paroi du flacon (pas directement sur le g\u00e2teau lyophilis\u00e9). Pour un flacon de 10 mg, 2,0 mL d'eau bact\u00e9riostatique donnent une concentration de travail de 5 mg\/mL ; 1,0 mL donne un stock de 10 mg\/mL. Pour un flacon de 5 mg, 1,0 mL d'eau bact\u00e9riostatique donne un stock de travail de 5 mg\/mL. Pour un flacon de 20 mg, 2,0 mL donnent un stock de travail de 10 mg\/mL. Agiter doucement \u2014 ne pas secouer vigoureusement, car la mousse emprisonne l'air et peut perturber les cha\u00eenes peptidiques. Laisser la poudre se dissoudre compl\u00e8tement (g\u00e9n\u00e9ralement &lt;1 minute pour le Pinealon) avant de pr\u00e9lever. Une fois reconstitu\u00e9, conserver le flacon \u00e0 2\u20138 \u00b0C et utiliser dans les 14\u201328 jours. Prot\u00e9ger de la lumi\u00e8re. Jeter en cas d&#039;opacit\u00e9, de particules ou de changement de couleur. <\/p>\n<h2>Questions fr\u00e9quemment pos\u00e9es<\/h2>\n<h3>Qu'est-ce que la famille des peptides courts de Khavinson et pourquoi le Pinealon en fait-il partie ?<\/h3>\n<p>The Khavinson short-peptide family is a series of 2- to 4-amino-acid peptides developed at the St. Petersburg Institute of Bioregulation and Gerontology by Vladimir Khavinson and colleagues, starting in the 1970s. The original studies extracted bioactive material from various cattle tissues (pineal, thymus, prostate, retina, etc.) and identified short peptide fragments responsible for tissue-specific bioregulatory effects. Pinealon (Glu-Asp-Arg) is the cognitive \/ neuroprotective compound in this series; <a href=\"https:\/\/medsbase.com\/fr\/epitalon\/\">Epitalon<\/a> (Ala-Glu-Asp-Gly) est le compos\u00e9 long\u00e9vit\u00e9 \/ t\u00e9lom\u00e9rase ; le Vilon, le Livagen, le Thymogen et d'autres ciblent d'autres tissus. <\/p>\n<h3>En quoi le Pinealon diff\u00e8re-t-il de l'Epitalon ?<\/h3>\n<p>Both are short Khavinson peptides extracted from cattle pineal-gland studies, but they have different sequences and different best-studied applications. Pinealon (Glu-Asp-Arg, tripeptide, +1 net charge) is studied for cognitive aging and neuroprotection. <a href=\"https:\/\/medsbase.com\/fr\/epitalon\/\">Epitalon<\/a> L'Epitalon (Ala-Glu-Asp-Gly, t\u00e9trapeptide, charge nette \u22122) est \u00e9tudi\u00e9 pour l'activation de la t\u00e9lom\u00e9rase et l'extension de la dur\u00e9e de vie. La charge nette oppos\u00e9e est une raison structurelle pour laquelle les deux peptides ciblent diff\u00e9rents loci g\u00e9nomiques selon le m\u00e9canisme propos\u00e9 de liaison directe \u00e0 l'ADN. <\/p>\n<h3>Quel est le m\u00e9canisme propos\u00e9 des peptides courts de Khavinson ?<\/h3>\n<p>The published Khavinson model holds that short charged peptides can cross the cell membrane and nuclear envelope, reach chromatin, and modulate gene expression through sequence-specific contacts with the DNA double helix at promoter regions. This is distinct from the canonical receptor-binding mechanism of larger peptides. The model is supported by studies from the Khavinson group spanning several decades and is the subject of continued mechanistic investigation by independent users. <\/p>\n<h3>Quelle peut \u00eatre la longueur minimale d'un peptide pour qu'il reste biologiquement actif ?<\/h3>\n<p>Pinealon at 3 amino acids is among the shortest pharmacologically-active peptides known. Even shorter examples exist (the dipeptide carnosine, the GLP-1 fragments, dipeptide HSP modulators), but most peptides are longer (10\u201340+ residues). The Khavinson short-peptide series is a focused area of studies specifically because the very short sequences allow rapid synthesis, easy crossing of cellular barriers, and clean structure-activity dissection. <\/p>\n<h3>Pourquoi la demi-vie plasmatique du Pinealon est-elle si courte ?<\/h3>\n<p>Les peptides courts charg\u00e9s sont rapidement \u00e9limin\u00e9s par filtration glom\u00e9rulaire et prot\u00e9olyse. Le Pinealon a une demi-vie plasmatique de seulement quelques minutes \u2014 pourtant les effets propos\u00e9s (modulation de l'expression g\u00e9nique, protection antioxydante, am\u00e9lioration comportementale) persistent pendant des heures \u00e0 des jours via des cascades de signalisation en aval. Ce profil est similaire \u00e0 celui d'autres peptides d\u00e9clencheurs de r\u00e9cepteurs o\u00f9 la dur\u00e9e est d\u00e9termin\u00e9e par la cin\u00e9tique de la cascade de signalisation plut\u00f4t que par une r\u00e9sidence plasmatique prolong\u00e9e. <\/p>\n<h3>What is the typical dose of Pinealon in rodent models?<\/h3>\n<p>Published rodent-model dose ranges span approximately 100 \u00b5g\u20134 mg per kg body weight per day, depending on route (subcutaneous most common), model (cognitive aging, MCAO, oxidative stress), and study duration. Subcutaneous administration is the standard administration route. Determine dose ranges from peer-reviewed literature appropriate to your specific protocol. <\/p>\n<h3>Le Pinealon a-t-il des effets en dehors du SNC ?<\/h3>\n<p>Pinealon is best-studied in CNS contexts (cognitive aging, neuroprotection, cerebral ischemia), but the proposed mechanism \u2014 direct nuclear access and gene-expression modulation \u2014 is in principle tissue-independent. Some published studies has examined peripheral effects (anti-oxidant in hepatic and renal models, immunomodulation in mixed-cell-culture systems), but the bulk of the literature centres on CNS readouts. <\/p>\n<h3>Existe-t-il une documentation \u00e9tablie avec un num\u00e9ro d'enregistrement CAS pour le Pinealon ?<\/h3>\n<p>Le CAS 308067-43-8 est le num\u00e9ro d'enregistrement le plus couramment cit\u00e9 dans les catalogues des fournisseurs de peptides, mais contrairement \u00e0 <a href=\"https:\/\/medsbase.com\/fr\/epitalon\/\">Epitalon<\/a> (which has a well-documented CAS 307297-39-8 across major reference databases), Pinealon&#8217;s CAS registration is less authoritatively published. Users requiring a regulatory-grade authoritative reference should verify against current CAS Registry sources. <!-- medsbase-related-alts-v1 --><\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705 Bioregulateur \u00e0 court peptide de Khavinson (tripeptide EDR)<br \/>\n\u2705 Acc\u00e8s nucl\u00e9aire direct propos\u00e9 + signalisation au niveau de la chromatine<br \/>\n\u2705 \u00c9tudi\u00e9 dans des mod\u00e8les de vieillissement cognitif et de neuroprotection<br \/>\n\u2705 Antioxydant + protecteur mitochondrial dans les cultures neuronales<br \/>\n\u2705 Similaire \u00e0 l'Epitalon (peptide de long\u00e9vit\u00e9)<\/p>\n<p><strong>Pinealon<\/strong> contient un compos\u00e9 peptidique synth\u00e9tique.<\/p>","protected":false},"featured_media":71407,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[6468,6467,5441,6466],"class_list":["post-71400","product","type-product","status-publish","has-post-thumbnail","product_cat-peptides","product_tag-edr","product_tag-khavinson","product_tag-peptide","product_tag-pinealon","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/product\/71400","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/comments?post=71400"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/media\/71407"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/media?parent=71400"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/product_brand?post=71400"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/product_cat?post=71400"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/product_tag?post=71400"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}